Hyderabad-based Dr Reddy’s Laboratories is the Indian partner of the Russian Direct Investment Fund, which has sought approval from the Indian drug regulator for use of single-dose Russia’s Sputnik Light one shot New Delhi: The Drugs Controller General of India has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine, informed Union Health Minister Mansukh Mandaviya on Sunday. “DCGI …
Three vaccines – Covovax, Biological E’s jab Corbevax, and Zydus Cadila’s ZyCoV-D vaccine – approved last year by the Drug Controller General of India for emergency use are yet to be rolled out in the vaccination drive. Experts opine that now is the right time to roll out the vaccines as India has started immunizing adolescents and giving precautionary dose …
Highlights A DCGI Committee recommended regular market approval to Covishield and Covaxin Covishield and Covaxin are currently only authorised for emergency use in the country SII and Bharat Biotech submitted applications to DCGI seeking regular market approval An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to Covid vaccines Covishield and Covaxin, which are …
The vaccine uses an older recombinant protein yeast fermentation technology similar to that used for the recombinant hepatitis B vaccine which has been around for 40 years. Our vaccine technology offers a path to address an unfolding humanitarian crisis, namely the vulnerability the low- and middle-income countries face against the delta variant,” said Dr Peter Hotez, professor and dean of …
The World Health Organisation on Sunday welcomed India's decision to give approval to Covid-19 vaccines for emergency use authorisation and said the move will "intensify and strengthen" the fight against the coronavirus pandemic. This decision taken today by India will help intensify and strengthen the fight against Covid-19 pandemic in the Region," Dr Poonam Khetrapal Singh, the regional director, WHO …